Literature DB >> 10781857

A possible explanation for the discrepancy between ELISA and neutralising antibodies to tetanus toxin.

J Dokmetjian1, C Della Valle, V Lavigne, C M de Luján, M A Manghi.   

Abstract

The structure and protective activity of tetanus antibodies elicited in rabbits after whole-cell pertussis diphtheria-tetanus vaccine (DTPw) vaccination was studied. ELISA antibody levels and toxin neutralisation activity (TNT) were measured in individual serum samples. The ratio of symmetric and asymmetric (functionally monovalent) IgG molecules was determined by concanavalin A (Con A) chromatography. This test is based on the fact that the carbohydrate group responsible for the molecular asymmetry has high affinity for the lectin Con A. Asymmetric molecule ratio was observed to increase with immunisation time, as well as differences between TNT and ELISA levels. All serum samples were overestimated by ELISA as compared to TNT assay, in line with the markedly higher proportion of asymmetric molecules which have lower toxin neutralising activity. Protective levels could not be predicted reasonably from ELISA results below 0. 222 IU/ml, because this methodology fails to discriminate between both types of antibodies and only an in vivo serum neutralisation procedure (TNT) reflects the true neutralising serum activity.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10781857     DOI: 10.1016/s0264-410x(00)00066-9

Source DB:  PubMed          Journal:  Vaccine        ISSN: 0264-410X            Impact factor:   3.641


  5 in total

1.  Tetanus Immunity among Women Aged 15 to 39 Years in Cambodia: a National Population-Based Serosurvey, 2012.

Authors:  Heather M Scobie; Bunsoth Mao; Sokhal Buth; Kathleen A Wannemuehler; Charlotte Sørensen; Chheng Kannarath; M Harley Jenks; Delynn M Moss; Jeffrey W Priest; Sann Chan Soeung; Michael S Deming; Patrick J Lammie; Christopher J Gregory
Journal:  Clin Vaccine Immunol       Date:  2016-07-05

2.  In vivo Evaluation of Single Dose Tetanus Toxoid Vaccine Formulation with Chitosan Microspheres.

Authors:  R Manivannan; S A Dhanaraj; Y Udaya Bhaskara Rao; A Balasubramaniam; N L Gowrishankar; N Jawahar; S Jubie
Journal:  Indian J Pharm Sci       Date:  2008-01       Impact factor: 0.975

3.  Production and characterisation of a neutralising chimeric antibody against botulinum neurotoxin A.

Authors:  Julie Prigent; Christelle Mazuet; Didier Boquet; Patricia Lamourette; Hervé Volland; Michel R Popoff; Christophe Créminon; Stéphanie Simon
Journal:  PLoS One       Date:  2010-10-08       Impact factor: 3.240

4.  Neutralising antibodies against ricin toxin.

Authors:  Julie Prigent; Laetitia Panigai; Patricia Lamourette; Didier Sauvaire; Karine Devilliers; Marc Plaisance; Hervé Volland; Christophe Créminon; Stéphanie Simon
Journal:  PLoS One       Date:  2011-05-25       Impact factor: 3.240

5.  An oligoclonal combination of human monoclonal antibodies able to neutralize tetanus toxin in vivo.

Authors:  Eduardo Aliprandini; Daniela Yumi Takata; Ana Lepique; Jorge Kalil; Silvia Beatriz Boscardin; Ana Maria Moro
Journal:  Toxicon X       Date:  2019-01-18
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.